Results 221 to 230 of about 2,291,402 (391)

Point of care and central laboratory determinations of the aPTT are not interchangeable in surgical intensive care patients [PDF]

, 2001
M. Ferring, Guido Reber, Philippe de Moerloose, Paolo Merlani, Marc Diby, Bara Ricou   +5 more
openalex   +1 more source

A DIA‐MS‐based proteomics approach to find potential serum prognostic biomarkers in glioblastoma patients

Molecular Oncology, EarlyView.
A DIA‐MS‐based proteomics analysis of serum samples from GB patients and healthy controls showed that high levels of IL1R2 and low levels of CRTAC1 and HRG in serum are associated with poor survival outcomes for GB patients. These circulating proteins could serve as biomarkers for the prediction of outcome in patients with GB.
Anne Clavreul, François Guillonneau, Odile Blanchet, Hamza Lasla, Audrey Rousseau, Catherine Guette, Alice Boissard, Cécile Henry, Morgan Dhondt, Pascal Jézéquel, Philippe Menei, Jean‐Michel Lemée   +11 more
wiley   +1 more source

ROM Plus®: accurate point-of-care detection of ruptured fetal membranes

Medical Devices: Evidence and Research, 2016
Ross W McQuivey,1 Jon E Block2 1Clinical Affairs, Clinical Innovations, Salt Lake City, UT, 2Independent Clinical Consultant, San Francisco, CA, USAAbstract: Accurate and timely diagnosis of rupture of fetal membranes is imperative to inform and guide ...
McQuivey RW, Block JE
doaj  

Measurement of Circulating Forms of Prostate-specific Antigen in Whole Blood Immediately after Venipuncture: Implications for Point-of-Care Testing [PDF]

, 2001
Timo Piironen, Martti Nurmi, Kerttu Irjala, Olli J. Heinonen, Hans Lilja, Timo Lövgren, Kim Pettersson   +6 more
openalex   +1 more source

EGFR‐STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1‐positive prostate cancer

Molecular Oncology, EarlyView.
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva, Bernardo Orr, Ana Azeredo, Andreia Brandão, Manuel R. Teixeira, Paula Paulo   +5 more
wiley   +1 more source

Rapid and simple point of care diagnostics for STIs [PDF]

, 2001
David Mabey
openalex   +1 more source

Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testing

Molecular Oncology, EarlyView.
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef, Hana Barhom, Sumit Chatterji, Netta Hecht, Oran Warhaftig, Iris Kamer, Oranit Zadok, Jair Bar, Limor Broday, Amir Onn, Michael Peled   +10 more
wiley   +1 more source

Bioluminescence in Clinical and Point-of-Care Testing. [PDF]

Biosensors (Basel)
Reyes S, Rodriguez R, Dikici E, Daunert S, Deo S.   +4 more
europepmc   +1 more source

Towards a quality and safety framework for point of care decision support systems

, 2000
Jonathan Bury, Julie Fox
openalex   +1 more source

Point-of-care testing: no pain, no gain [PDF]

, 2001
Michael J. Murphy
openalex   +1 more source